An allopurinol adherence tool using plasma oxypurinol concentrations.
Natalia Smith-DiazSophie Lena StockerLisa K StampNicola DalbethAmanda J Phipps-GreenTony R MerrimanDaniel F B WrightPublished in: British journal of clinical pharmacology (2022)
A tool to identify people with gout who require additional support to maintain adherence using plasma oxypurinol concentrations was developed and evaluated. The predictive performance of the tool is suitable for adherence screening in clinical trials and may have utility in some clinical practice settings.